دورية أكاديمية

Lafora Disease: A Case Report

التفاصيل البيبلوغرافية
العنوان: Lafora Disease: A Case Report
المؤلفون: Ebru APAYDIN DOĞAN, Faik İLİK, Zeliha Esin ÇELİK, Bülent Oğuz GENÇ, Muhammed Nebil SELİMOĞLU
المصدر: Archives of Epilepsy, Vol 22, Iss 1, Pp 32-36 (2016)
بيانات النشر: Galenos Yayinevi, 2016.
سنة النشر: 2016
المجموعة: LCC:Neurology. Diseases of the nervous system
LCC:Medicine
مصطلحات موضوعية: lafora disease, perampanel, progressive myoclonic epilepsy, Neurology. Diseases of the nervous system, RC346-429, Medicine
الوصف: Lafora disease (LD) is a progressive myoclonus epilepsy with autosomal recessive inheritance. Clinical course is progressive and includes myoclonic, cerebellar, and extrapyramidal signs, generalized tonic-clonic seizures, and cognitive decline. Valproic acid, zonisamide, levetiracetam, clonazepam, and piracetam are among the treatment options. Carbamazepine (CBZ), oxcarbazepine, phenytoin, and lamotrigine (LM) should be avoided to prevent worsening of symptoms. Though evidence is limited, perampanel is the only drug to achieve sustained improvement in frequency of seizures, and effective control of neurological and cognitive decline in patients with LD. Described in the present report is a case of typical LD with clinical worsening on CBZ and LM treatment. Electroencephalographic and pathologic findings are reported.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2792-0550
العلاقة: http://archepilepsy.org/archives/archive-detail/article-preview/lafora-disease-a-case-report/55060Test; https://doaj.org/toc/2792-0550Test
DOI: 10.5505/epilepsi.2016.74755
الوصول الحر: https://doaj.org/article/a2584c7f535943b3910a898d38899005Test
رقم الانضمام: edsdoj.2584c7f535943b3910a898d38899005
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:27920550
DOI:10.5505/epilepsi.2016.74755